approval />
BRUSSELS — European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval.
Sourse: abcnews.go.com
approval />
BRUSSELS — European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval.
Sourse: abcnews.go.com